The health authority’s decision was the final approval necessary for the merger to proceed.
The Federal Trade Commission raised objections to the proposed merger on two separate occasions, stating the merger would increase costs for patients and decrease the quality of care. Officials from both hospitals responded, saying the FTC’s view on the merger is “very narrow” and only focused on the competition.
Officials said the merged entity would be named Ballad Health.
More articles on transactions and valuations:
Trending: More children’s hospitals are partnering with local facilities
This week’s 5 most-read transactions and valuations stories
MedPac discusses policy options in light of consolidation trend
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
